Latest Breaking News On - Algernon pharma - Page 1 : comparemela.com

Algernon Pharmaceuticals Inc considers potential spin-off of its NP-120 (Ifenprodil) chronic cough research program

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) has said it is considering the potential spin-off of its NP-120 (Ifenprodil) chronic cough research.

Christopherj moreauAlgernon pharmaJacky smithPeter dicpinigaitisAlgernon pharmaceuticals incMaxim groupMerck coMarket researchAlgernon pharmaceuticalsData bridge market researchRespiratory medicineInternal medicinePulmonary diseasesAlgernon neuroscience

Biotech Co Set To Reach New Highs

Biotech Co. Set To Reach New Highs

United statesChristopher bryanAlgernon pharmaChristopherj moreauAhmad khalilAmanda duvallStreetwise reportsAlgernon pharmaceuticals incAlgernon pharmaceuticalsAustralia therapeutic goods administrationExchange commissionNewswire algernon pharmaceuticals incAlgernon neuroscienceVice presidentClinical trialsTherapeutic goods administration

Algernon Pharmaceuticals Inc announces successful dosing of second cohort in Phase 1 DMT clinical study

Algernon Pharmaceuticals Inc announces successful dosing of second cohort in Phase 1 DMT clinical study
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Algernon pharmaChristopher moreauAlgernon pharmaceuticals incAlgernon pharmaceuticalsCentre for human drug researchExchange commissionAlgernon neuroscienceHuman drug research

Algernon Pharmaceuticals Inc says wholly-owned subsidiary s Reg A+ offering gets US SEC qualification

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its wholly-owned subsidiary, Algernon NeuroScience (AGN Neuro), has qualified its Form 1-A.

Algernon pharmaChristopherj moreauIssuance incAlgernon pharmaceuticals incDalmore groupExchange commissionAlgernon pharmaceuticalsAlgernon neuroscience

Algernon Pharmaceuticals Inc says unit initiates traumatic brain injury research program with DMT; appoints global TBI expert as advisor

Algernon Pharmaceuticals Inc says unit initiates traumatic brain injury research program with DMT; appoints global TBI expert as advisor
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

Glasgow cityUnited kingdomAlgernon pharmaChristopher moreauAndrew maasDavid menonInternational mission on prognosisInternational brain injury associationAntwerp university hospitalBurdenko institute of neurosurgeryConstraint induced movement therapyAlgernon pharmaceuticals incExchange commissionUniversity of cambridgeCentre for human drug researchCollaborative european neurotrauma effectiveness research